Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.71%
1,092.80
-7.77
-0.71%
—1,100.571,098.941,103.801,084.24——
SIXC
Communications
SIXC
Communications
SIXC
-0.07%
604.74
-0.41
-0.07%
—605.15605.15606.69602.76——
SIXE
Energy
SIXE
Energy
SIXE
+1.64%
1,214.80
+19.61
+1.64%
—1,195.191,204.711,221.691,204.71——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.88%
1,724.57
-15.34
-0.88%
—1,739.911,734.501,734.501,710.67——
SIXM
Financials
SIXM
Financials
SIXM
+0.14%
639.43
+0.87
+0.14%
—638.56640.21645.32638.69——
SIXR
Staples
SIXR
Staples
SIXR
+0.91%
839.15
+7.58
+0.91%
—831.57840.48844.16834.54——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+1.06%
215.62
+2.26
+1.06%
—213.36213.36215.79212.77——
SIXT
Technology
SIXT
Technology
SIXT
-1.69%
3,179.52
-54.66
-1.69%
—3,234.183,171.863,195.363,145.46——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.13%
936.91
+1.26
+0.13%
—935.65937.31941.44933.16——
SIXV
Health care
SIXV
Health care
SIXV
+0.24%
1,452.77
+3.51
+0.24%
—1,449.261,454.771,462.651,447.95——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.72%
2,365.18
-17.27
-0.72%
—2,382.452,371.192,380.452,362.86——
SHTDY:OTCMKTS
Sinopharm Group ADR
$11.76
-0.08%
(-0.010) 1D
Apr 28, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SHTDY...
Open
$11.75
High
$11.76
Low
$11.62
Mkt. cap
58.61B
Avg. vol.
63.38K
Volume
91.34K
52-wk high
$14.87
52-wk low
$10.84
Beta
0.30
Shares outstanding
268.36M
No. of employees
95K
News stories
From sources across the web
Profile
Sinopharm Group Co., Ltd. is a Chinese pharmaceutical company. The parent company of Sinopharm Group was Sinopharm Industrial Investment, a 51–49 joint venture of state-owned enterprise China National Pharmaceutical Group and civilian-run enterprise Fosun Pharmaceutical. Its H shares were listed on the Hong Kong Stock Exchange in 2009, with its IPO price of HK$16 per share. Sinopharm Group's subsidiary Sinopharm CNMC and Sinopharm Accord served as the A share counterpart of the company. However, the A share of Sinopharm Group itself was unlisted. Sinopharm Group was ranked 829th in 2016 Forbes Global 2000 list. Wikipedia
About Sinopharm Group ADR
CEO-
Employees94.9K
Founded2003
Headquarters-
SectorHealth care provider
Websitesinopharm.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
144.38B
145.44B
143.69B
17.82B
Cost of goods sold
133.92B
134.52B
133.28B
17.45B
Cost of revenue
133.92B
134.52B
133.28B
17.45B
Research and development expenses
-63.26M
172.61M
-172.61M
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6.08B
5.17B
7.34B
-
Operating expense
5.92B
6.80B
5.00B
-
Total operating expenses
139.84B
141.32B
138.29B
17.45B
Operating income
4.54B
4.12B
5.40B
376.59M
Other non operating income
-70.05M
120.78M
-427.44M
273.60K
EBT including unusual items
4.27B
3.67B
3.92B
376.86M
EBT excluding unusual items
4.44B
3.51B
5.36B
376.86M
Income tax expense
1.18B
905.42M
1.19B
89.40M
Effective tax rate
27.76%
24.66%
30.30%
23.72%
Other operating expenses
-514.77M
917.07M
-1.10B
-
Net income
2.01B
1.84B
1.85B
287.46M
Net profit margin
1.39%
1.27%
1.29%
1.61%
Earnings per share
-
-
-
-
Interest and investment income
-
364.24M
-
-
Interest expense
-710.99M
-412.56M
-846.59M
-
Net interest expenses
-710.99M
-48.32M
-846.59M
-
Depreciation and amortization charges
-
-
-
-
EBITDA
5.10B
4.66B
5.91B
940.90M
Gain or loss from assets sale
-11.79M
11.79M
-20.53M
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer